EndoRotor® Features

Determine your resection limits – instead of your instruments imposing their limitations on you. The EndoRotor® allows you to simultaneously dissect, resect and collect tissue. This 3-in-1 endoscopic interventional tool provides features that complement today’s GI toolkit.
  • Endoluminal preservation – EndoRotor enables resection of scarred lesions without removing muscle, maintaining lumen patency and avoiding surgery1,2,3

  • Non-thermal mechanical resection of persistent adenoma1,2,3

  • Non-thermal mechanical resection and removal of necrotic tissue in symptomatic WOPN/WON4,5,6

  • Used clinically to facilitate EMR lateral margins and tissue bridges1,2,3

  • Potential to replace multiple instruments and eliminate instrument exchange time

Above left: EndoRotor Console on Pole. Above right: Close-up of EndoRotor Console

The EndoRotor® product overview sheet provides a range of information including: product features, FAQs, a colon procedure before and after example, pathology reports, and several physician testimonials.

Endoluminal Surgery

How do you preserve your patient’s lumen?

Direct Endoscopic Necrosectomy

Solutions where drainage is not enough? Come understand our newest research.

Figure 1 Before
(10cm x 7cm x 6cm collection 50%) debridement

Figure 2 After
one debridement session

Advancement in Endoscopic Tools

FAQs

How does the EndoRotor work? . . .

The EndoRotor is an endoluminal surgical tool for debriding tissue not amenable to conventional instrument resection. Tissue is aspirated into the catheter and cut simultaneously. Aspirated tissue is available for histopathologic analysis.

How does the EndoRotor help me? What are the advantages over how I perform resection today? . . .

The incidence of incomplete resection during EMR is well documented throughout clinical literature. Because of combined suction and rotation, the instrument allows the user to remove residual tissue without the need to lift, including post-EMR scarred lesions and lateral margins in primary resections. The EndoRotor® is a versatile tool that is not limited by tissue morphology.

What about pathological specimens? . . .

The EndoRotor has FDA clearance for use by gastroenterologists to resect and remove residual tissue from the peripheral margins following Endoscopic Mucosal Resection (EMR). Procedures completed by physicians globally routinely involve specimens evaluated by pathologists without challenge.

What about margins? . . .

In a recent series (Emmanuel et al.) following wide field EMR, physicians used magnification chromoendoscopy in to confirm negative margins. Using the EndoRotor to resect the margins, pathology revealed a 13% residual tissue in the margins and base previously shown as negative by magnification chromoendoscopy. There were no recurrences at follow up. 7

What about perforation or bleeding? . . .

The EndoRotor has been in use globally since 2016. Prophylactic epinephrine helps to mitigate bleeding risk. Perforation risk is within the standards of reported literature.

Where can I use the device? . . .

The EndoRotor is cleared for use by a trained gastroenterologist to resect and remove residual tissue, not intended for biopsy, of the gastrointestinal (GI) system including post-endoscopic mucosal resection (EMR) tissue persistence with a scarred base and residual tissue from the peripheral margins following EMR.

Are there any studies being done? . . .

For investigational use for these indications: The EndoRotor is currently under investigation for the removal of walled-off pancreatic necrosis during direct endoscopic necrosectomy and for refractory Barrett’s mucosa. View Ongoing Clinical Studies | View Completed Clinical Trials

 
 
 

Thank you for your interest in contacting Interscope.
We look forward to addressing your questions or requests. All fields are required.

 
 
 
 

1 Kaul, Vivek, et al. Safety and efficacy of a novel powered endoscopic debridement tissue resection device for management of difficult colon and foregut lesions: first multicenter U.S. experience. Gastrointestinal Endoscopy, 2020, doi:10.1016/j.gie.2020.06.068.

2 Kandiah K, et al. A novel non-thermal resection tool in endoscopic management of scarred polyps. Endosc Int Open. 2019;Aug;7(8):E974-E978. doi: 10.1055/a-0838-5424.

3 Ayub K, et al. Safety and efficacy of the novel EndoRotor mucosal resection system: first multicenter USA experience. Am J Gastroenterol. 2019;Oct;114:S502-S503. doi: 10.14309/01.ajg.0000593000.03914.0d.

4 Soota K, et al. Experience with endorotor-xt for endoscopic necrosectomy in patients with acute necrotic pancreatitis at a tertiary care center. Gastrointestinal Endoscopy, vol. 91, no. 6, 2020, doi:10.1016/j.gie.2020.03.1133.

5 Schlag C, et al. Endoscopic microdebrider-assisted necrosectomy for walled-off pancreatic necrosis. Endoscopy. 2020;52(S01):S29-S30. doi: 10.1055/s-0040-1704093.

6 van der Wiel SE, et al. Preliminary report on the safety and utility of a novel automated mechanical endoscopic tissue resection tool for endoscopic necrosectomy: a case series. Endosc Int Open. 2020;Mar;8(3):E274-E280. doi: 10.1055/a-1079-5015.

7 Emmanuel A, et al. The incidence of microscopic residual lesion left after apparent complete wide-field EMR of large colorectal superficial neoplastic lesions: evidence for the pathophysiological mechanism of recurrence. Digestive Disease Week Poster No 1087, 2018.